Primary Stenting in a Patient with Acute Myocardial Infarction and Primary Antiphospholipid Syndrome
- Volume 14 - Issue 4 - April, 2002
- Posted on: 8/1/08
- 0 Comments
- 5995 reads
Antiphospholipid syndrome (APS) is an uncommon thrombotic disorder characterized by antiphospholipid antibodies (aPL). The syndrome may be associated with arterial or venous thrombosis, thrombocytopenia, recurrent fetal loss, skin lesions, neurological complications and retinal occlusion.1 Premature myocardial infarction may also be seen as a part of APS. In coronary artery bypass graft (CABG) operations and coronary balloon angioplasty (PTCA), APS may lead to complications such as bypass graft closure2 and early failure of PTCA.3,4 Although the patients with APS frequently have positive lupus anticoagulant activity, only a minority of these patients have satisfying diagnostic criteria for systemic lupus erythematosis (SLE). Thus, APS without the clinical features of SLE is called primary antiphospholipid syndrome.5 We present a case of primary stenting in a patient with primary APS who had recurrent coronary thrombosis without any other thrombotic disorder.